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Abstract
Background: Hong Kong (HK) and Guangzhou (GZ) are cities in China with different healthcare systems. This study
aimed to compare 30-day and 6-month mortality and characteristics of patients with suspected cardiac chest pain
admitted to two emergency departments (ED) in HK and GZ.
Methods: A prospective observational study enrolled patients with suspected cardiac chest pain presenting to
EDs in the Prince of Wales Hospital (PWH), HK and the Second Affiliated Hospital of Guangzhou Medical University
(AHGZMU),GZ. The primary outcome was 30-day and 6-month mortality.
Results: In total, 996 patients were recruited, 407 cases from GZ and 589 cases from HK.The 30-day and 6-month
mortality of chest patients were 3.7% and 4.7% in GZand 0.3% and 1.9% in HK, respectively. Serum creatinine level
(Cr) was an independent factor for 30-day mortality whilst Cr and systolic blood pressure (SBP) were independent
factors for 6-month mortality. In Cox regression analysis, unadjusted and adjusted hazard ratios for 30-day and
6-month mortality in GZ were significantly increased.
Conclusion: The 30-day and 6-month mortality of patients with suspected cardiac chest pain in Guangzhou were
higher than in Hong Kong due to due to different baseline clinical characteristics of patients and different distributions
of diagnoses, which were associated with different healthcare systems. Serum creatinine and SBP were independent
factors for 30-day and 6-month mortality.
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Backgroud
Chest pain is a common chief complaint of patients
presenting to emergency departments (ED) globally,
and it places a huge burden on ED services [1–3]. The
challenge for clinicians is the dual danger of discharging
patients at potential high risk and the clinical pressure of
EDs crowded with low risk patients. In order to improve
the quality of care and survival rates of cardiac patients,
there is a worldwide impetus to develop and improve
systems for emergency cardiac care [4]. Current guide-
lines emphasize rapid determination of the likelihood that
the patient’s clinical presentation represents high risk
chest pain, such as acute coronaryartery disease, and rapid
assessment of the immediate risk for a major adverse car-
diac event (MACE) [5]. Hong Kong (HK) and Guangzhou
(GZ) are cities in southern China with almost the same
ethnicity but different healthcare systems [6]. The health-
care system of HK has adopted health care financing and
organizational health systems that are commonly seen in
centrally planned economies. In contrast, mainland China
has integrated many features of health care systems associ-
ated with market economies, whereas both have advanced
* Correspondence: cagraham@cuhk.edu.hk
2Accident and Emergency Medicine Academic Unit, Chinese University of
Hong Kong, Prince of Wales Hospital, Main Clinical Block and Trauma Centre,
Shatin, N.T, Hong Kong, China
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jiang et al. BMC Cardiovascular Disorders  (2018) 18:95 
https://doi.org/10.1186/s12872-018-0814-4
systems of chest pain care in EDs [7–9]. So the healthcare
systems of the two cities are quite different under the “one
country, two systems” policy [10]. No study has compared
clinical outcomes of susceptive cardiac chest pain patients
with similar ethnicity under different healthcare systems,
and the influence factor of its outcome. Our previous study
has compared the clinical ED management and one-year
mortality of ST-segment elevation myocardial infarction
(STEMI) patients between the two hospitals in HK and GZ
[11]. After that, the comparable registries of chest pain
database have been developed in Guangzhou and Hong
Kong. The objective of the study was to compare 30-day
and 6-month outcomes of patients with suspected cardiac
chest pain presenting to two EDs in HK and GZ, and con-
tributory factors of outcomes.
Methods
Study design and setting
A prospective cohort study conducted from May 2012
to August 2013 in two teaching hospitals.
The Second Affiliated Hospital of Guangzhou Medical
University (AHGZMU)is an academic hospital with 1500
beds affiliated with the Guangzhou Medical University and
serves a population of approximately 1.56 million people in
the Hai Zhu district, Guangzhou. The ED receives more
than 150,000 new patients per annum and serves a local
population of approximately 1,680,000 people. The Prince
of Wales Hospital (PWH) is located in the New Territories
in Hong Kong. It is a university hospital with 1400 beds. It
sees approximately 150,000 new ED patients per annum and
serves a local population of approximately 800,000 people.
Inclusion and exclusion criteria
Consecutive ED patient ≥18 years old, with a chief com-
plaint of chest pain or discomfort were recruited. Pa-
tients were excluded if they clearly had a non-cardiac
cause of chest pain. Confirmed STEMI patients at ED
presentation were also excluded as they did not have un-
differentiated chest pain. Patients were excluded if
they were unable or unwilling to provide informed con-
sent or unable to be contacted after discharge.
Measurements and data collection
Baseline patient characteristics, the characteristics of the
chest pain (such as location, feature and radiation), vital
signs, medical history, family history of coronary artery
disease (CAD), ECG results and contact information to fa-
cilitate subsequent follow-up were collected and recorded
in a computerized database. The HEART score was re-
corded and calculated by research staff. The details of the
HEART score are shown in Additional file 1. Guidelines
recommend that patients with possible ACS but with a
normal initial ECG and cardiac markers should be ob-
served in a chest pain unit, where continuous cardiac
monitoring and repeated measurement of cardiac markers
is available [12]. Point-of care troponin testswere used in
GZ, whilst high sensitivity troponin tests were used in HK.
Therefore, the results of troponin were divided into four
groups (≤1× normal range, 1×-2× normal range, 2×-3×
normal range and ≥ 3× normal range) for analysis. ST-
depression on initialECG means ST depression ≥1.0mv in
any lead of the initial ECG. The onset-ED time and ED-
ECG time were recorded. Follow-up data were obtained
from the Clinical Management System (CMS) in HK and
Health Insurance Information Management System
(HIIMS) in GZ.
Follow up
Subsequent visits to ED, hospital readmission for evalu-
ation of chest pain and all cardiac procedures performed
were retrieved from CMS in HK and HIIMS in GZ, and
verified via telephone at 30-days and 6-months follow-
up after initial presentation. Furthermore, death, myo-
cardial infarction, readmission for ACS, and all cardiac
testing and coronary revascularization procedures were
also obtained via CMS and HIIMS.
Sample size calculation
According to our previous study [7], the 30-day MACE
rates in Chinese patients presenting to ED with cardiac
chest pain could have been as high as the upper limit of
the 95% confidence interval in the low-risk group i.e.
13%, and as low as the lower limit of the 95% confidence
interval in the high-risk group i.e. 23%. To achieve ad-
equate power to address the objectives by using 2-tailed
alpha of 0.05 and a power of 80%, the minimum sample
size required per group is 220. We aimed to recruit an
extra 30% in case of unforeseen circumstances and thus
at least 230 (230 × 1.3 = 299) patients were required per
group. Therefore, the minimum sample size in this study
was 598 (299 × 2 recruiting sites = 598).
Outcomes
The primary outcomefor each patient wasall cause mor-
tality within 30 days and 6 monthsafter initial ED pres-
entation. The secondary outcomes were the contributory
factors of primary outcomes.
Statistical analyses
Continuous variables were presented as median and
interquartile range or mean ± standard deviation as ap-
propriate. Categorical variables were expressed as fre-
quencies. Statistical analysis was performed using SPSS
v17.0 (SPSS Inc., IL, USA) and Medcalc v9.5 (MedCalc
Software, Mariakerke, Belgium). Summary statistics were
used to describe patient characteristics from the Hong
Kong and Guangzhou groups. Chi-square analysis was
used for categorical variables, whilst independent t-tests
Jiang et al. BMC Cardiovascular Disorders  (2018) 18:95 Page 2 of 10
or Mann-Whitney U-tests were used for comparing data
from continuous variables. An initial univariate analysis
was performed on all variables with 30-day and 6-month
mortalityas the dependent variables and presented as
unadjusted odds ratios (OR) and 95% confidence inter-
vals (95% CI). Variables with p ≤ 0.1 were entered into a
multivariate ordinal logistic regression. Cumulative sur-
vival curves in relation to different hospitals were de-
termined according to the Kaplan-Meier method with
the use of log-rank tests for statistical assessment. Cox
regression analysis was used to calculate unadjusted
and adjusted hazard ratios (HRs) and 95% CIs for
mortality rates after 30 days and 6 months in relation
to different hospitals. A P value of < 0.05 was consi-
dered statistically significant and all probabilities were
two tailed.
Results
Recruitment of patients from the two centers
Patients were recruited from 17 March 2012 to 14 Au-
gust 2013. The flow chart of the patient recruitment was
shown in Fig. 1. There were 1025 eligible patients, with
589 cases in HK and 436 cases in GZ. Twenty-nine pa-
tients were excluded due to lack of follow-up data, leav-
ing 996 patients (407 cases from GZ and 589 cases from
HK) in the study. The mean age of the 996 patients was
65.1 ± 14.5 years and 55.3% were males.
Baseline characteristics and final diagnoses of chest pain
patients
Table 1 shows the characteristics of chest pain patients
from GZ and HK. Compared to patients in HK, patients in
GZ were older and had lower proportions of past history of
diabetes, hyperlipidaemia and chronic heart failure, lower
proportion of NHYA class I and lower blood pressure.
Troponin is a key biomarker to detect myocardial injury in
the two hospitals. Troponin was used as a myocardial injury
biomarker in 98% patients in HK and 70% patients in GZ.
Creatine kinase (CK) and creatine kinase isoenzyme-MB
(CK-MB) were the predominant biomarkers used in GZ, in
which 98% patients had a CK level determined. However,
these tests were rarely used in HK. Ischaemic cardiac chest
pain was diagnosed in 120 (29.4%) patients in GZ (9.8%
with NSTEMI, 16.0% with unstable angina and 3.7% with
stable angina). Non-ischaemic cardiac aetiologies and non-
cardiac aetiologies were found in 136 (33.4%) and 151
(37.1%) patients respectively. In HK, 163 (27.7%) patients
had ischaemic cardiac chest pain, including 5.4%
with NSTEMI, 12.1% with unstable angina and 10.2%
with stable angina. 84 (14.3%) patients were diagnosed as
having non-ischaemic cardiac aetiologies and 342 (58.1%)
were diagnosed with non-cardiac aetiologies. There were
significant differences in the number of cases diagnosed
with non-ischaemic cardiac aetiologies and non-cardiac
chest pain between GZ and HK (P < 0.0001), whilst there
was no significant difference in the number of cases
diagnosed with ischaemic cardiac chest pain between the
two hospitals.There were no significant differences in the
number of readmission of 30-day and 6-month.
Comparison of clinical outcomes of chest pain patients in
the two centres
Table 2 shows the 30-day and 6-month mortality of chest
painpatients. The 30-day mortality rates for ischaemia,
Fig. 1 Flow chart of eligible patients in the two hospitals
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Table 1 Comparison of patient characteristics between the two hospitals (N = 996)
AHGZMU (n = 407) PWH (n = 589) P
Age, years, mean (SD) 66.6 (14.4) 63.7 (14.6) 0.002*
Males, n (%) 220 (54.1) 325 (55.2) 0.726
Past histories
Smoker, n (%) 69 (17.0) 78 (13.2) 0.105
Hypertension, n (%) 245 (60.2) 362 (60.9) 0.688
Diabetes, n (%) 79 (19.4) 153 (26.0) 0.016*
Hyperlipidemia, n (%) 92 (22.6) 266 (45.2) < 0.0001*
Chronic heart failure, n (%) 26 (6.4) 62 (10.5) 0.024*
Family heart disease, n (%) 72 (17.7) 125 (21.2) 0.169
Stroke, n (%) 26 (6.4) 72 (12.2) 0.002*
Peripheral arterial disease, n (%) 6 (1.5) 20 (3.4) 0.062
NHYA classification
NHYA class I, n (%) 234 (57.5) 401 (68.1) 0.001*
NHYA class II, n (%) 118 (29.0) 75 (12.7) < 0.0001
NHYA class III, n (%) 51 (12.5) 108 (18.3) 0.014*
NHYA class IV, n (%) 4 (1.0) 5 (0.8) 0.826
First ED characteristics
Heart rate, bpm, mean (SD) 88.4 (27.8) 82.0 (19.1) < 0.0001*
Systolic blood pressure, mmHg, mean (SD) 141.3 (30.1) 148.7 (25.9) 0.001*
Diastolic blood pressure, mmHg, mean (SD) 78.2 (17.0) 80.1 (15.4) 0.018
First lab results in ED
Creatinine, μmoL/L, median (IQR) 88.0 (71.0, 109.0) 81.0 (66.0, 97.0) < 0.0001*
Troponin
≤ 1× 224 (78.9) 420 (72.4) < 0.0001*
1×-2× 21 (7.4) 85 (14.7) < 0.0001*
2×-3× 8 (2.8) 22 (3.8) 0.108
≥ 3× 31 (10.9) 53 (9.1) 0.441
Number of CK done, n (%) 399 (98.0) 339 (57.6) < 0.0001*
Number of CK-MB done, n (%) 399 (98.0) 0 (0) < 0.0001*
ST segment depression, n (%) 80 (8.0) 19 (1.9) < 0.0001*
Onset- ED time,hour, median (IQR) 4.03 (1.5–13.21) 6.52 (2.01–23.27) < 0.0001*
ED-ECG time, hour, median (IQR) 0.17 (0.03–0.47) 0.18 (0.12–0.28) 0.234
HEART Score, median (IQR) 4 (3,6) 4 (2,5) < 0.0001*
Number of admission 231 (56.8) 334 (56.7) 0.987
Final diagnoses
Ischemia coronary chest pain 120 (29.5) 163 (27.7) 0.534
NSTEMI, n (%) 40 (9.8) 32 (5.4)
Unstable angina, n (%) 65(16.0) 71(12.1)
Stable angina, n (%) 15 (3.7) 60 (10.2)
Non-ischaemia cardiac chest pain, n (%) 136 (33.4) 84 (14.3) < 0.0001*
Non-cardiac chest pain, n (%) 151 (37.1) 342 (58.1) < 0.0001*
*statistically significant
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non-ischaemic cardiac and non-cardiac causes in GZwere
1.5%, 1.0% and 1.7% respectively. No one died of ischaemia
and non-ischaemia cardiac aetiologies in HK up to 30-days
follow-up. The 30-day mortality rates for non-cardiac causes
was 0.7% in HK. The 6-month mortality rates of ischaemic
chest painin GZ were statistically higher than those in HK.
The 6-month mortality of ischemia, non-ischaemic
cardiac and non-cardiac causes in GZ were 1.7%, 1.2%
and 1.7% respectively, whilst in HK these were 0.3%, 0.5%
and 1.0% respectively. NSTEMI patients demonstrated a
higher mortality than other ischaemic chest pain patients
at 30-day and 6-month follow-up. Compared with cardiac
aetiologies, higher mortality was observed for non-cardiac
causes. Most diagnoses of non-cardiac chest pain were
pulmonary embolism, pneumonia, ischemia stroke and
cancer (see Table 2 for details).
Univariate and multivariate logistic regression for 30-day
and 6-month mortality
Table 3 shows patients were more likely to die after
30 days if they were older, had ST-segment deviation, a
history of worse NHYA class and lower SBP and
DBP, higher serum creatinine and troponin level at ED
admission, and a higher HEART score. After multivariate
logistic regression, serum creatinine level was the only
independent predictor of 30-day mortality.
Table 4 shows patients were more likely to die by 6
months if they were older, had ST-segment depression, a
history of chronic heart failure, hyperlipidemia and
worse NHYA class, lower SBP, higher serum creatinine
and troponin level at ED admission, and higher HEART
score. After multivariate logistic regression, serum cre-
atinine level and SBP were the only independent predic-
tors of 6-month mortality.
Survival analysis in two hospitals
Figure 2 showed the corresponding Kaplan-Meier event-
free survival curves for different hospitals. Kaplan-Meier
analysis demonstrated a significantly increased probabil-
ity of death ofchest pain patients in GZ after 30 days
and 6 months (P < 0.0001 for 30-day mortality using the
log-rank test, and P = 0.010 for 6-month mortality using
the log-rank test).
In Cox regression analysis, the unadjusted HR for 30-day
(HR = 11.05, 95% CI 2.53 to 48.32, P = 0.001) and 6-month
(HR = 2.55, 95% CI 1.22 to 5.37, P = 0.013) mortality in GZ
was significantly higher (Table 5). After adjusting for age,
SBP, ST segment depression, NHYA classification, troponin,
HEART score and serum creatinine, the adjusted HR for
30-day (HR = 8.98, 95% CI 1.78 to 45.2, P = 0.008) mortality
in GZ was still significantly higher.
After adjusting for age, hyperlipidemia, CHF, SBP,
ST segment depression, NHYA classification, troponin,
HEART score and serum creatinine, the adjusted HR for
6-month (HR = 1.77, 95% CI 0.73 to 4.26, P = 0.205) mor-
tality in GZ was not significantly higher than that in HK.
Discussion
This is the first prospective cohort study to compare 30-
day and 6-month mortality of suspected cardiac chest pain
patients admitted to EDs between two teaching hospi-
tals located in two different cities in southern China
with similar ethnicity but differenthealthcare systems
[11]. The chest pain patients in GZ had a higher 30-day
and 6-month mortalitythan in HK. The findings suggest
that the different outcomes were associated with the
varying clinical characteristics of patients and different
distributions of diagnoses under two differenthealthcare
systems. GZ has integrated many features of healthcare
system associated with market economies, while its
Table 2 Comparison of 30-day and 6-month mortality in patients with different diagnoses between the two hospitals (N = 996)
30-day mortality in GZ
(n = 407)
30-day mortality in HK
(n = 589)
P 6-month mortality in GZ
(n = 407)
6-month mortality in HK
(n = 589)
P
Final diagnoses
Ischemia coronary chest
pain
6 (1.5) 0 (0) 0.005* 7 (1.7) 2 (0.3) 0.036*
NSTEMI, n (%) 4 (1.0) 0 (0) 5 (1.2) 1 (0.2)
Unstable angina, n (%) 2 (0.5) 0 (0) 2 (0.5) 0 (0)
Stable angina, n (%) 0 (0) 0 (0) 0 (0) 1 (0.2)
Non-ischaemia cardiac
causes, n (%)
4 (1.0) 0 (0) 0.28 5 (1.2) 3 (0.5) 0.283
Non-cardiac causes, n (%) 5 (1.2) 2 (0.3) 0.129 7 (1.7) 6 (1.0) 0.339
Total 15 (3.7) 2 (0.3) < 0.0001* 19 (4.7) 11 (1.9) 0.011
The death reasons of non-cardiac chest pain were: pulmonary embolism = 1 in GZ, pneumonia = 1in GZ and 3 in HK, ischaemic stroke = 1 in GZ, cancer = 1 in GZ
and 3 in HK, other reasons = 3 in GZ
The death reasons of non-ischaemic cardiac chest pain were: heart failure = 2in GZ and 2 in HK, Valvular heart disease = 1 in HK, Aortic dissection = 3 in GZ
*statistically significant
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overall economy is largely centrally planned. In con-
trast,Hong Kong adopt thehealthcare system are come
from England and organizational health systems that
are commonly seen in centrally planned economies,
while its economy functions as a highly capitalisticen-
terprise [10, 13].
Different distributions of chest pain patients between two
hospitals
Over 50% of patients were diagnosed as non-cardiac chest
pain in HK, a much higher rate than in GZ (37.1%). This
may reflect the different healthcare systems. In Guangzhou,
chest pain patients at low risk often present to clinics instead
of EDs during office hours. The ED is the only choice for
patients with chest pain in HK due to lower medical costs.
So, the patients with urgent and severe chest pain/symptoms
would likely to present to EDs in GZ. Compared to other
studies, the proportion of non-cardiac chest pain patientsin
this study was low. The proportions in GZ and HK were
50% and 37.1% respectively compared to 67.2%–70% in
other studies [14–16]. A lower proportion of non-cardiac
chest pain patients may allow earlier discharge from the
ED and place less stress on ED and hospital services.
There were no significant differences in 30-day and 6-
month mortality for non-ischemic cardiac chest pain
and non-cardiac chest pain between the two hospitals.
However, there was significantly higher 30-day and 6-
month mortality rates for ischemic cardiac chest pain
patients in GZ. ACS is a high-risk disease with signifi-
cant mortality [9, 17]. The current study excluded
STEMI patients but NSTEMI and UA patients were
recruited. The combined proportion of NSTEMI and
UA in GZ was 25.8%, which was higher than thatin HK
(17.5%). The proportions of NSTEMI and UA were also
higher than those in Cullen’s study (8.7%) whilst non
ACS cardiovascular-related conditions were 20.8% [14].
Different clinical characteristics and outcomes of patients
between two hospitals
Since the patients with severe chest pain/symptoms would
likely to present to EDs in GZ while those patients with
mild chest pains/symptoms would visit clinics, so the
baseline clinical characteristicsof patients in GZ were
worse than those in HK. The patients were older, had
lower proportion of NHYA class I and higher creatinine
level, higherproportion of ST-segment depression, lower
Table 3 Univariate and multivariate logistic regression for 30-day mortality (N = 996)
Unadjusted Odds Ratio (95% CI) P Adjusted Odds Ratio (95% CI) P
Age, years 1.069 (1.023–1.117) 0.003* 1.031 (0.977-1.089) 0.262
Males (vs Females) 2.008 (0.702–5.744) 0.193
Past histories
Smoker (vs non smoker) 2.256 (0.644–7.905) 0.204
Hypertension (vs non hypertension) 1.094 (0.413–2.899) 0.857
Diabetes (vs non diabetes) 0.702 (0.2–2.464) 0.58
Hyperlipidemia (vs non hyperlipidemia)
CHF (vs non CHF) 2.254 (0.635–7.998) 0.209
FHD (vs non FHD) 1.153 (0.328–4.053) 0.824
Stroke (vs non stroke) 0.568 (0.075–4.332) 0.586
PAD (vs non PAD)
First ED characteristics
Heart rate 1.003 (0.982–1.024) 0.804
SBP 0.980 (0.962–0.990) 0.044* 0.990 (0.963-1.089) 0.486
DBP 0.973 (0.942–1.005) 0.1 1.02 (0.97–1.072) 0.435
NHYA class III, IV (vs NHYA class I,II) 3.557 (1.334–9.481) 0.011* 1.554 (0.405-5.972) 0.521
Troponin Elevation ≥2× (vs < 2×) 10.385 (1.228–87.874) 0.032* 2.471 (0.613-9.955) 0.203
Creatinine elevation (vs normal) 11.643 (3.947–34.347) < 0.0001* 9.189 (2.319-36.407) 0.002*
ST segment depression (vs normal) 0.175 (0.061–0.5) 0.001* 1.026 (0.973-1.083) 0.34
HEART Score 1.622 (1.228–2.143) 0.001* 0.706 (0.404-1.231) 0.22
Onset- ED time 0.966 (0.919–1.015) 0.172
ED-ECG time 1 (1–1) 0.949
CHF Chronic heart failure, FHD Family history of heart disease PAD Peripheral arterial disease, SBP Systolic blood pressure, DBP Diastolic blood pressure
Adjusted for age, SBP, DBP,ST segment depression, NHYA classification, troponin, HEART score and serum creatinine
*statistically significant
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proportion of negative TnT and higher HEART scoreat
ED presentation. Those factors have also been shown to
be associated with 30-day and 6-month mortality. The
same parameters have been verified to predict short- and
long-term risks of death from ACS [18–24]. Compared to
HK, lower proportions of patients with risk factors
were seen in GZ, whilst more patients with worse NHYA
class were observed. This suggests that many chest pain
patients in GZ did not have any knowledge of cardiac risk
factors and were unaware of the presence of those risk
factors, therefore the impact of those risk factors might be
underestimated. Early detection and good control of risk
factors for suspected cardiac chest pain patients may re-
duce mortality.
Furthermore, elevated serum creatinine level was an
independent predictor for 30-day and 6-month mortal-
ity in our study.It has also been reported to be associated
with worse outcomes for ACS and critically ill patients
[18, 23]. Elevated serum creatinine can reflect vascular
damage, renal impairment, endothelial dysfunction and im-
paired myocardial blood flow [24–27]. A multinational
registry study by Tang et al. showed that SBP could predict
the 6-month mortality of all subsets of ACS. As SBP
increases by 10 mmHg, the hazard ratio would decrease by
0.95 [27].
Several studies have reported that the HEART score is
not only related to the severity of chest pain in EDs but
also predicts the occurrence of clinical endpoints [28–
32]. Our study also demonstrated that the HEART score
was positively associated with 30-day and 6-month mor-
tality of suspected cardiac chest pain patients in the ED
setting.
The dissimilarity of healthcare systems in the two cit-
ies is another reason for the different ED management.
Limited capacity of hospital emergency care services,
high out-of-pocket expenses with the need for up-front
payment, prolonged discussions with the patient and
families for both obtaining consent and pooling funds are
likely to be major contributing factors for the long pre-
hospital, in-hosptial delay and refused some expensive
treatments [13, 32].
In ED chest pain pathways, guidelines recommend
that an ECG should be recorded within 10 min and
myocardial injury biomarkers should be measured as
soon as possible in all suspected cardiac chest pain pa-
tients [4, 9]. The ED-ECG time and the proportion of
Table 4 Univariate and multivariate logistic regression for 6-month mortality (N = 996)
Unadjusted Odds Ratio (95% CI) P Adjusted Odds Ratio (95% CI) P
Age, years 1.074 (1.038–1.112) < 0.0001* 1.033 (0.98-1.088) 0.233
Males (vs Females) 0.508 (0.230–1.121) 0.093 0.592 (0.17–2.053) 0.592
Past histories
Smoker (vs non smoker) 0.755 (0.332–1.715) 0.502
Hypertension (vs non hypertension) 1.291 (0.598–2.789) 0.515
Diabetes (vs non diabetes) 1.002 (0.425–2.367) 0.996
Hyperlipidemia (vs non hyperlipidemia) 0.191 (0.058–0.635) 0.007* 0.00 (0.00-0.00) 0.996
CHF (vs non CHF) 4.812 (2.132–10.861) < 0.0001* 3.454 (0.705-16.93) 0.126
FHD, (vs non FHD) 0.442 (0.133–1.473) 0.184
Stroke (vs non stroke) 1.019 (0.303–1.473) 0.976
PAD (vs non PAD) 1.298 (.170–9.909) 0.801
First ED characteristics
Heart rate 1.007 (0.993–1.022) 0.318
SBP 0.979 (0.965–0.993) 0.004* 0.974 (0.95-0.999) 0.045*
DBP 0.977 (0.954-1.001) 0.061 1.045 (0.998–1.094) 0.114
NHYA class III, IV (vs NHYA class I,II) 5.314 (2.545–11.095) < 0.0001* 2.519 (0.685-9.266) 0.165
Troponin Elevation ≥ 2× (vs < 2×) 8.04 (1.693–38.185) 0.009* 2.983 (0.494-18.01) 0.233
Creatinine elevation (vs normal) 11.137 (4.23–29.326) < 0.0001* 7.48 (2.042-27.369) 0.002*
ST segment depression (vs normal) 4.190 (1.968–8.917) < 0.0001* 1.006 (0.954-1.061) 0.815
HEART Score 1.603 (1.310–2.027) < 0.0001* 0.81(0.487-1.349) 0.418
Onset- ED time 0.986 (0.964–1.008) 0.216
ED-ECG time 1.00 (1.000–1.000) 0.922
CHF Chronic heart failure, FHD Family history of heart disease, PAD Peripheral arterial disease, SBP Systolic blood pressure, DBP Diastolic blood pressure
Adjusted for age, gender, hyperlipidemia, CHF, SBP, DBP, ST segment depression, NHYA classification, troponin, HEART score and serum creatinine
*statistically significant
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patients having myocardial injury biomarkers measured
in both hospitals met these guidelines.Myocardial injury
biomarkers, such as troponin, CK and CK-MB are used
to identify myocardial injury [33]. Many studies have
shown that troponinis superior to CK and CK-MB as a
biomarker for detection of myocardial injury [19, 20].
Therefore, troponin testing is recommended in most
guidelines for its high sensitivity and specificity [17].
However in GZ, CK and CK-MB are still mainly used for
the diagnosis of AMI and ACS due to their lower costs.
High expenses with the need for up-front payment of
troponin testing are likely to be a major contributing
factor for the lower rate of use of troponin testing in GZ.
The lower sensitivities and specificities of CK and CK-
MB might contribute to the delayed diagnoses of AMI/
ACS and later treatment of patients, possibly contribut-
ing to the higher early mortality in GZ. Except the mor-
taliy, readmissions after ACS are associated with higher
long-term all-cause mortality [34].However, our study
did not show the significant difference of 30-day and
6-month readmission rate in in HK and GZ. The reason
was that the patients we enrolled were suspected car-
diac chest pain patients instead of ACS.
Strengths and limitations
The strengths of this study include the fact it is the first
comparison of outcomes in different healthcare systems
in a similarly populated region of southern China, which
effectively eliminates many confounding factors in any
comparison. The current study also has some limita-
tions, including the sample size of this study which met
our precalculated size but may still be considered small
by international standards. Secondly, patient risk factors
(i.e. the past medical histories) may have been underesti-
mated due to variations in history taking between the
two centres. Thirdly, as a prospective observational
study, propensity score with matching would attempt to
reduce the bias due to confounding variables. However,
this method requires large sample size. Also, the proced-
ure only controls for observed variables, so any hidden
bias due to latent variables may remain after matching.
Logistic regression and Cox regression can meet the
need of this study.
Conclusion
The 30-day and 6-month mortality of patients with sus-
pected cardiac chest pain in Guangzhou were higher
than in Hong Kong due to different baseline clinical char-
acteristics of patients at ED presentation and different dis-
tributions of diagnoses which were associated with
different healthcare systems. Serum creatinine and SBP
were independent predictors of 30-day and 6-month
Table 5 Unadjusted and adjusted hazard ratios of all-cause
mortality at 30-days and 6-months in the two hospitals
HR(95% CI) P Adjusted HR (95% CI) P
30-day all-cause mortality
GZ 11.05 (2.53–48.32) 0.001* 8.98 (1.78-45.2) 0.008*
HK Reference Reference
6-month all-cause mortality
GZ 2.55 (1.22–5.37) 0.013* 1.77 (0.73-4.26) 0.205
HK Reference Reference
30-day mortality was adjusted for age, SBP, DBP, ST segment depression,
NHYA classification, troponin, HEART score and serum creatinine
6-month mortality was adjusted for age, gender, hyperlipidemia, CHF, SBP,
DBP, ST segment depression, NHYA classification, troponin, HEART score and
serum creatinine
*statistically significant
Fig. 2 Kaplan-Meier event-free survival curves in GZ and HK. Kaplan-Meier analysis demonstrated a significant increased probability of mortality
during 30-day (Log Rank P < 0.0001) and 6-month follow-up in GZ (Log Rank P = 0.010)
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mortality. Improved patient knowledge of risk factors
along with early detection and good control of risk factors
may lead to better outcomes for cardiac chest pain pa-
tients in southern China.
Additional file
Additional file 1: Definition of HEART score [29]: There were five
elements: history, ECG, age,risk factors and troponin in HEART score. Each
variable was scored as 0, 1 or 2 points. Each patient will receive a score
of 1-10. (DOCX 32 kb)
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